Exact Mass: 455.1234

Exact Mass Matches: 455.1234

Found 26 metabolites which its exact mass value is equals to given mass value 455.1234, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Apafant

3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0²,⁶]trideca-2(6),4,7,10,12-pentaen-4-yl]-1-(morpholin-4-yl)propan-1-one

C22H22ClN5O2S (455.1183)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents

   

Aristolactam I N-beta-glucoside

Aristolactam I N-beta-glucoside

C23H21NO9 (455.1216)


   

DTXSID50703458

DTXSID50703458

C23H21NO9 (455.1216)


   

Cys Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C15H29N5O5S3 (455.1331)


   

Cys Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C15H29N5O5S3 (455.1331)


   

Cys Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N5O5S3 (455.1331)


   

Lys Cys Cys Cys

(2R)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C15H29N5O5S3 (455.1331)


   

XL388

XL388

C23H22FN3O4S (455.1315)


XL388 is a highly potent and ATP-competitive mTOR inhibitor with an IC50 of 9.9 nM. XL388 simultaneously inhibits both mTORC1 and mTORC2. XL388 is a highly potent and ATP-competitive mTOR inhibitor with an IC50 of 9.9 nM. XL388 simultaneously inhibits both mTORC1 and mTORC2.

   

2 5-BIS(CHLOROMETHYL)-1 4-BIS(BUTOXY)BE&

2 5-BIS(CHLOROMETHYL)-1 4-BIS(BUTOXY)BE&

C26H21N3O3S (455.1304)


   

TETRAETHYLAMMONIUM TETRACHLOROMANGANATE&

TETRAETHYLAMMONIUM TETRACHLOROMANGANATE&

C16H40Cl4MnN2 (455.1326)


   

Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate

Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate

C28H22ClNO3 (455.1288)


   

primaquine phosphate

primaquine phosphate

C15H27N3O9P2 (455.1222)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

Methyl 2-(3-{3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl}-3-oxopropyl)benzoate

Methyl 2-(3-{3-[2-(7-chloroquinolin-2-yl)vinyl]phenyl}-3-oxopropyl)benzoate

C28H22ClNO3 (455.1288)


   

4,8-bis(thiophen-2-yl)-6-(2-ethylhexyl)-[1,2,5]thiadiazolo[3,4-f]benzotriazole

4,8-bis(thiophen-2-yl)-6-(2-ethylhexyl)-[1,2,5]thiadiazolo[3,4-f]benzotriazole

C22H25N5S3 (455.1272)


   

N-(3,5-dimethylphenyl)-2-[(4-oxo-3-phenyl-2-benzofuro[3,2-d]pyrimidinyl)thio]acetamide

N-(3,5-dimethylphenyl)-2-[(4-oxo-3-phenyl-2-benzofuro[3,2-d]pyrimidinyl)thio]acetamide

C26H21N3O3S (455.1304)


   

{4-[2,2-Bis(5-methyl-1,2,4-oxadiazol-3-YL)-3-phenylpropyl]phenyl}sulfamic acid

{4-[2,2-Bis(5-methyl-1,2,4-oxadiazol-3-YL)-3-phenylpropyl]phenyl}sulfamic acid

C21H21N5O5S (455.1263)


   

Apafant

Apafant

C22H22ClN5O2S (455.1183)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents

   

(E)-1-(glutathion-S-yl)-N-hydroxy-2-(4-hydroxyphenyl)ethan-1-imine

(E)-1-(glutathion-S-yl)-N-hydroxy-2-(4-hydroxyphenyl)ethan-1-imine

C18H23N4O8S- (455.1237)


   

3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide

3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide

C23H22ClN3O5 (455.1248)


   

Benzylpenicilloyl cysteine

Benzylpenicilloyl cysteine

C19H25N3O6S2 (455.1185)


   

N-(2-methoxyphenyl)-5-methyl-3-(1-naphthalenylmethyl)-4-oxo-6-thieno[2,3-d]pyrimidinecarboxamide

N-(2-methoxyphenyl)-5-methyl-3-(1-naphthalenylmethyl)-4-oxo-6-thieno[2,3-d]pyrimidinecarboxamide

C26H21N3O3S (455.1304)


   

2-[[benzyl-[(2-fluorophenyl)methyl]carbamothioyl]amino]-N-[(4-chlorophenyl)methyl]acetamide

2-[[benzyl-[(2-fluorophenyl)methyl]carbamothioyl]amino]-N-[(4-chlorophenyl)methyl]acetamide

C24H23ClFN3OS (455.1234)


   

4,7-DI(4-Methoxyphenyl)-6-(2-methoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine

4,7-DI(4-Methoxyphenyl)-6-(2-methoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine

C26H21N3O3S (455.1304)


   

ST 18:5;O6;Tau

ST 18:5;O6;Tau

C20H25NO9S (455.125)


   

14-methoxy-10-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

14-methoxy-10-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

C23H21NO9 (455.1216)


   

14-methoxy-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

14-methoxy-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,5-dioxa-10-azapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one

C23H21NO9 (455.1216)